Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
150 participants
OBSERVATIONAL
2019-09-01
2045-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Is Family Screening Improved by Genetic Testing of Familial Hypercholesterolemia
NCT04526457
Identifying and Genotyping Homozygous Familial Hypercholesterolemia (HoFH) Patients
NCT04148001
Gene Analysis and Treatment Optimization in Chinese Homozygous Familial Hypercholesterolemia
NCT01878604
Elevated Serum HDL in Four Generations of a Nashville Family
NCT00525109
Genetic Analysis of Hereditary Disorders of Hearing and Balance
NCT00023049
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The included patients will undergo physical examination and extended blood sampling. DNA will be extracted and used for both whole genome sequencing and investigation of both known- , unknown- and suspected mutations associated with FH.
The patients will be followed in for 15 years in the Swedish patients registry and the Swedish cause of death registry.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Patients with high clinical suspicion of familial hypercholesterolemia. No intervention.
No intervention
No intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
No intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Clinical suspicion of FH
3. Dutch Lipid Clinic Network Score of at least four or a first grade relative with a genetic deviation that may be associated with FH.
Exclusion Criteria
8 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Region Örebro County
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anna M Nordenskjöld, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Örebro University, Sweden
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Örebro University hospital
Örebro, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
262231
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.